Would like to see an ongoing forum on this topic so admore data becomes available, more educated decisions csn be made. Specifically, protocol for staying on Keytruda while NED.
The patient 62 year old male. Diagnosed with Stage IV adeo nsclc following a pleural effusion. Cancer was in lung, pleural cavity, lymph nodes, upper abdomen. Pdl expression of 80%.
Has been on Keytruda for just three months, and remarkably, PET scan shows full remission, NED. No side effects ftom the Keytruda.
Any new data on the potential of the immune system to learn to find the cancer after use? Any protocols established re:continuing treatment?